We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Government Subpoenas Biogen Over the Prices, Rebates of Four Therapies
Federal Government Subpoenas Biogen Over the Prices, Rebates of Four Therapies
The federal government issued a subpoena to Biogen requesting information on prices, rebates and co-assistance programs for four of its therapies, according to an SEC filing by the company.